GE Healthcare and cardiovascular software developer HeartFlow have signed a global collaboration agreement to boost the clinical availability of HeartFlow FFR-CT, a technology that helps clinicians diagnose and treat patients with coronary artery disease.
HeartFlow FFR-CT will be incorporated into GE's line of Revolution CT scanners and its CardioGraphe dedicated cardiovascular CT system. The collaboration will also include GE's clinical applications such as CardIQ, VesselIQ, and transcatheter aortic valve implantation (TAVI) planning, the two firms said.
